{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:43:32Z","timestamp":1763642612088},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12519-019-00257-z","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T06:03:19Z","timestamp":1556776999000},"page":"159-167","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of tacrolimus and low-dose prednisone in Chinese children with steroid-resistant nephrotic syndrome"],"prefix":"10.1007","volume":"16","author":[{"given":"Hai-Xia","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Nan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu-Wen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Chuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"257_CR1","doi-asserted-by":"crossref","unstructured":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr. 1981;98:561\u20134.","DOI":"10.1016\/S0022-3476(81)80760-3"},{"key":"257_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2215\/CJN.09010912","volume":"8","author":"K Nakanishi","year":"2013","unstructured":"Nakanishi K, Iijima K, Ishikura K, Hataya H, Nakazato H, Sasaki S, et al. Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome. Clin J Am Soc Nephrol. 2013;8:756\u201362.","journal-title":"Clin J Am Soc Nephrol."},{"key":"257_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.gene.2017.04.050","volume":"625","author":"Y Wang","year":"2017","unstructured":"Wang Y, Dang X, He Q, Zhen Y, He X, Yi Z, et al. Mutation spectrum of genes associated with steroid-resistant nephritic syndrome in Chinese children. Gene. 2017;625:15\u201320.","journal-title":"Gene."},{"key":"257_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3345\/kjp.2011.54.8.322","volume":"54","author":"SJ Park","year":"2011","unstructured":"Park SJ, Shin JI. Complications of nephrotic syndrome. Korean J Pediatr. 2011;54:322\u20138.","journal-title":"Korean J Pediatr."},{"key":"257_CR5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00467-009-1138-5","volume":"24","author":"D Mekahli","year":"2009","unstructured":"Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E, et al. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol. 2009;24:1525\u201332.","journal-title":"Pediatr Nephrol."},{"key":"257_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"Kidney Disease Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group","year":"2012","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Inter Suppl. 2012;2:139\u2013274.","journal-title":"Kidney Inter Suppl"},{"key":"257_CR7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","volume":"53","author":"S Choudhry","year":"2009","unstructured":"Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Efficacy and safety of Tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis. 2009;53:760\u20139.","journal-title":"Am J Kidney Dis."},{"key":"257_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrneph.2011.171","volume":"8","author":"PW Mathieson","year":"2011","unstructured":"Mathieson PW. The podocyte as a target for therapies\u2014new and old. Nat Rev Nephrol. 2011;8:52\u20136.","journal-title":"Nat Rev Nephrol."},{"key":"257_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","volume":"17","author":"AW Thomson","year":"1995","unstructured":"Thomson AW, Bonham CA, Zeevi A. Mode of action of Tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit. 1995;17:584\u201391.","journal-title":"Ther Drug Monit."},{"key":"257_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ndt\/gfq617","volume":"26","author":"E Sch\u00f6nenberger","year":"2011","unstructured":"Sch\u00f6nenberger E, Ehrich JH, Haller H, Schiffer M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant. 2011;26:18\u201324.","journal-title":"Nephrol Dial Transplant."},{"key":"257_CR11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14:931\u20138.","journal-title":"Nat Med."},{"key":"257_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MAJ.0b013e31824ce676","volume":"345","author":"W Chen","year":"2013","unstructured":"Chen W, Liu Q, Liao Y, Yang Z, Chen J, Fu J, et al. Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial. Am J Med Sci. 2013;345:81\u20137.","journal-title":"Am J Med Sci."},{"key":"257_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/nep.12991","volume":"22","author":"D Xu","year":"2017","unstructured":"Xu D, Gao X, Bian R, Mei C, Xu C. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease. Nephrology (Carlton). 2017;22:251\u20136.","journal-title":"Nephrology (Carlton)."},{"key":"257_CR14","first-page":"33","volume":"96","author":"S Supavekin","year":"2013","unstructured":"Supavekin S, Surapaitoolkorn W, Kurupong T, Chaiyapak T, Piyaphanee N, Sumboonnanonda A. Tacrolimus in steroid resistant and steroid dependent childhood nephritic syndrome. J Med Assoc Thai. 2013;96:33\u201340.","journal-title":"J Med Assoc Thai."},{"key":"257_CR15","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00467-009-1220-z","volume":"24","author":"L Butani","year":"2009","unstructured":"Butani L, Rajendra R. Experience with tacrolimus in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2009;24:1517\u201323.","journal-title":"Pediatr Nephrol."},{"key":"257_CR16","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/ndt\/gfq813","volume":"26","author":"C Morgan","year":"2011","unstructured":"Morgan C, Sis B, Pinsk M, Yiu V. Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome. Nephrol Dial Transplant. 2011;26:2860\u20135.","journal-title":"Nephrol Dial Transplant."},{"key":"257_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s004670000480","volume":"15","author":"JT Flynn","year":"2000","unstructured":"Flynn JT, Pasko DA. Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension. Pediatr Nephrol. 2000;15:302\u201316.","journal-title":"Pediatr Nephrol."},{"key":"257_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1440-1797.2006.00667.x","volume":"11","author":"L Miao","year":"2006","unstructured":"Miao L, Sun J, Yuan H, Jia Y, Xu Z. Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation. Nephrology (Carlton). 2006;11:449\u201354.","journal-title":"Nephrology (Carlton)."},{"key":"257_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet. 2018;392:61\u201374.","journal-title":"Lancet."},{"key":"257_CR20","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00467-015-3133-3","volume":"30","author":"A Jahan","year":"2015","unstructured":"Jahan A, Prabha R, Chaturvedi S, Mathew B, Fleming D, Agarwal I. Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2015;30:1961\u20137.","journal-title":"Pediatr Nephrol."},{"key":"257_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/ijn.IJN_240_16","volume":"28","author":"N Prasad","year":"2018","unstructured":"Prasad N, Manjunath R, Rangaswamy D, Jaiswal A, Agarwal V, Bhadauria D, et al. Efficacy and safety of cyclosporine versus tacrolimus in steroid and cyclophosphamide resistant nephrotic syndrome: a prospective study. Indian J Nephrol. 2018;28:46\u201352.","journal-title":"Indian J Nephrol."},{"key":"257_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.autrev.2016.12.005","volume":"16","author":"TT Qiu","year":"2017","unstructured":"Qiu TT, Zhang C, Zhao HW, Zhou JW. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: a systematic review and meta-analysis of 21 clinical trials. Autoimmun Rev. 2017;16:136\u201345.","journal-title":"Autoimmun Rev."},{"key":"257_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/ndt\/17.4.655","volume":"17","author":"A Segarra","year":"2002","unstructured":"Segarra A, Vila J, Pou L, Maj\u00f3 J, Arb\u00f3s A, Quiles T, et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant. 2002;17:655\u201362.","journal-title":"Nephrol Dial Transplant."},{"key":"257_CR24","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1093\/ndt\/gfh536","volume":"19","author":"N Duncan","year":"2004","unstructured":"Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, Mclean AG, et al. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transplant. 2004;19:3062\u20137.","journal-title":"Nephrol Dial Transplant."},{"key":"257_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1517\/13543784.16.7.1099","volume":"16","author":"TH Westhoff","year":"2007","unstructured":"Westhoff TH, van der Giet M. Tacrolimus in the treatment of idiopathic nephrotic syndrome. Expert Opin Investig Drugs. 2007;16:1099\u2013110.","journal-title":"Expert Opin Investig Drugs."},{"key":"257_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00467-003-1370-3","volume":"19","author":"K Loeffler","year":"2004","unstructured":"Loeffler K, Manjula G, Verna Y. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome. Pediatr Nephrol. 2004;19:281\u2013327.","journal-title":"Pediatr Nephrol."},{"key":"257_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/ndt\/gfm688","volume":"23","author":"S Gulati","year":"2008","unstructured":"Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children. Nephrol Dial Transplant. 2008;23:910\u20133.","journal-title":"Nephrol Dial Transplant."},{"key":"257_CR28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1159\/000097864","volume":"26","author":"R Bhimma","year":"2006","unstructured":"Bhimma R, Adhikari M, Asharam K, Connolly C. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus. Am J Nephrol. 2006;26:544\u201351.","journal-title":"Am J Nephrol."},{"key":"257_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/nep.12351","volume":"20","author":"B Wu","year":"2015","unstructured":"Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, et al. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. Nephrology (Carlton). 2015;20:18\u201324.","journal-title":"Nephrology (Carlton)."},{"key":"257_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/ndt\/gfu306","volume":"30","author":"J Caro","year":"2015","unstructured":"Caro J, Guti\u00e9rrez-Sol\u00eds E, Rojas-Rivera J, Aqraz I, Ramos N, Rabasco C, et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. Nephrol Dial Transplant. 2015;30:467\u201374.","journal-title":"Nephrol Dial Transplant."},{"key":"257_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00005792-197907000-00002","volume":"58","author":"EA Brown","year":"1979","unstructured":"Brown EA, Upadhyaya K, Hayslett JP, Kashgarian M, Siegel NJ. The clinical course of mesangial proliferative glomerulonephritis. Medicine (Baltimore). 1979;58:295\u2013303.","journal-title":"Medicine (Baltimore)."},{"key":"257_CR32","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/jclinpath-2012-200933","volume":"65","author":"S Shakeel","year":"2012","unstructured":"Shakeel S, Mubarak M, Kazi JI, Lanewala A. The prevalence and clinicopathological profile of IgM nephropathy in children with steroid-resistant nephrotic syndrome at a single centre in Pakistan. J Clin Pathol. 2012;65:1072\u20136.","journal-title":"J Clin Pathol."},{"key":"257_CR33","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","volume":"27","author":"W Wang","year":"2012","unstructured":"Wang W, Xia Y, Mao J, Chen Y, Wang D, Shen H, et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol. 2012;27:2073\u20139.","journal-title":"Pediatr Nephrol."},{"key":"257_CR34","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1681\/ASN.2004070593","volume":"16","author":"S Troyanov","year":"2005","unstructured":"Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol. 2005;16:1061\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"257_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12519-014-0484-y","volume":"10","author":"M Kallash","year":"2014","unstructured":"Kallash M, Diego A. Efficacy of Tacrolimus in the treatment of children with focal segmental glomerulosclerosis. World J Pediatr. 2014;10:151\u20134.","journal-title":"World J Pediatr."},{"key":"257_CR36","first-page":"337","volume":"13","author":"KN Moorani","year":"2003","unstructured":"Moorani KN, Khan KM, Ramzan A. Infections in children with nephrotic syndrome. J Coll Physicians Surg Pak. 2003;13:337\u20139.","journal-title":"J Coll Physicians Surg Pak."},{"key":"257_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/BF00866719","volume":"9","author":"S Gulati","year":"1995","unstructured":"Gulati S, Kher V, Gupta A, Arora P, Rai PK, Sharma RK. Spectrum of infections in Indian children with nephrotic syndrome. Pediatr Nephrol. 1995;9:431\u20134.","journal-title":"Pediatr Nephrol."}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-019-00257-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-019-00257-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-019-00257-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T23:38:16Z","timestamp":1588289896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-019-00257-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1007\/s12519-019-00257-z","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]},"assertion":[{"value":"22 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study protocol was approved by Local Ethics Committee of The Second Xiangya Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}},{"value":"No financial benefits have been received from any party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}]}}